Home › Trial NCT01118039
Sunitinib Malate in Treating Patients With Locally Recurrent, Locally Advanced, Unresectable, or Metastatic Urinary Tract Cancer
- Trial IDNCT01118039
- StatusUnknown
- PhasePhase 2
- Study typeInterventional
- SponsorHospital del Mar
- Enrollment41
- Start date2006-07
- ConditionsBladder Cancer · Transitional Cell Cancer of the Renal Pelvis and Ureter · Urethral Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.